Retraction:

Zhihong Zhao^1,*, Jue Hu^2,*, Xiaoping Gao¹, Hui Liang¹, Haiya Yu³, Suosi Liu^1,4 and Zhan Liu⁴

¹Department of Neurology, The First Affiliated Hospital (People’s Hospital of Hunan Province), Hunan Normal University, Changsha, Hunan, China
²Department of Neurology, Changsha Central Hospital, Changsha, Hunan, China
³Department of Neurology, The People’s Hospital of Xishui, Huangang, Hubei, China
⁴Department of Clinical Nutrition and Gastroenterology, The First Affiliated Hospital (People’s Hospital of Hunan Province), Hunan Normal University, Changsha, Hunan, China
^*These authors contributed equally to this work

Published: November 22, 2024

Copyright: © 2024 Zhao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: The authors contacted Oncotarget, stating, ‘In this paper, we occasionally reused some western blot bands for other papers. For multiple errors in our paper, we want to retract our paper published in your journal.’ Oncotarget requested an investigation by the authors’ institution (The First Affiliated Hospital (People’s Hospital of Hunan Province), Hunan Normal University, Changsha, Hunan, China) but we received no reply. Oncotarget conducted an internal image forensics report that revealed several instances of overlap between figures from previously published unrelated papers [1–3] and a concurrently published paper [4]. Specifically, Figure 6C duplicates Figure 4A of [1]; Figure 1C duplicates Figure 1E of the paper, which has been retracted [2]; Figure 6, panels A and B, duplicates images in Figure 3A of [3]; Figure 1, panels A and B, duplicates Figure 1, panels A and B, of another paper [4]; Figure 2, panels A and B, duplicates Figure 2, panels A and B of [4]; Figure 3, panels A, B and C, duplicates Figure 3, panels A, B and C, of [4]; Figure 5, panels A, B and C, duplicates Figure 4, panels A, B and C of [4]. As a result, the Editorial decision was made to retract this paper. All authors agreed with the decision.

REFERENCES

1. Li X, Dai Y, Yan S, Shi Y, Li J, Liu J, Cha L, Mu J. Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production. Clin Exp Hypertens. 2016; 38:287–93. https://doi.org/10.3109/10641963.2015.1089882. [PubMed]
2. Xu BC, Long HB, Luo KQ. Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasomePTEN-Akt-eNOS pathway. Sci Rep. 2016; 6:29589. https://doi.org/10.1038/srep29589. [PubMed]. Retraction in: Sci Rep. 2019; 9:17122. https://doi.org/10.1038/s41598-019-53022-7. [PubMed]
3. Wang J, Kong D, Zhang S, Jiang H, Zheng Y, Zang Y, Hao H, Jiang Y. Interaction of fibrinogen and muramidase-released protein promotes the development of Streptococcus suis meningitis. Front Microbiol. 2015; 6:1001. https://doi.org/10.3389/fmicb.2015.01001. [PubMed]
4. Xie X, Sun W, Wang J, Li X, Liu X, Liu N. Activation of thromboxane A2 receptors mediates endothelial dysfunction in diabetic mice. Clin Exp Hypertens. 2017; 39:312–318.https://doi.org/10.1080/10641963.2016.1246558. [PubMed]

Original article: Oncotarget. 2017; 8:30030–30038. DOI: https://doi.org/10.18632/oncotarget.16273.